Skip to main content
logo
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.125
-0.040 (-1.26%)
Oct 9, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Biotechnology
154.29M74.15M7.70M5.69M13.81M
Total
154.29M74.15M7.70M5.69M13.81M

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
United States of America
154.20M74.01M--
PRC
97.00K139.00K386.00K538.00K
Total
154.29M74.15M386.00K538.00K